Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David L Thomas

Showing results (31-40 of 483) with videos related to

Pageof 49
Sort By:
Clinics in Liver Disease|April 15, 2003
Hepatitis C in the HIV-infected patientMark S Sulkowski, David L Thomas
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|May 4, 2024
The Blood Virome: A new frontier in biomedical scienceAbraham J Kandathil, David L Thomas
AIDS (London, England)|October 28, 2005
Perspectives on HIV/hepatitis C virus co-infection, illicit drug use and mental illnessMark S Sulkowski, David L Thomas
Gastroenterology|February 27, 2010
Interleukin-28b: a key piece of the hepatitis C virus recovery puzzleChloe L Thio, David L Thomas
Journal of Addictive Diseases|August 7, 2008
Detection of liver disease in injection drug usersDavid L Thomas, Mark S Sulkowski
JAMA|March 29, 2012
Screening for HCV infection in jailsAnne C Spaulding, David L Thomas
Annals of Internal Medicine|February 1, 2003
Hepatitis C in the HIV-Infected PersonMark S Sulkowski, David L Thomas
AIDS Research and Human Retroviruses|July 13, 2018
HIV-1 Infection and Type 1 Interferon: Navigating Through Uncertain WatersSho Sugawara, David L Thomas, Ashwin Balagopal
Magnetic Resonance in Medicine|February 27, 2013
Orthogonalizing crusher and diffusion-encoding gradients to suppress undesired echo pathways in the twice-refocused spin echo diffusion sequenceZoltán Nagy, David L Thomas, Nikolaus Weiskopf
Current Opinion in HIV and AIDS|November 6, 2018
Creating demand for long-acting formulations for the treatment and prevention of HIV, tuberculosis, and viral hepatitisCharles Flexner, David L Thomas, Susan Swindells
Pageof 49

Showing results (31-40 of 483) with videos related to

Sort By:
Pageof 49
Clinics in Liver Disease|April 15, 2003
Hepatitis C in the HIV-infected patientMark S Sulkowski, David L Thomas
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|May 4, 2024
The Blood Virome: A new frontier in biomedical scienceAbraham J Kandathil, David L Thomas
AIDS (London, England)|October 28, 2005
Perspectives on HIV/hepatitis C virus co-infection, illicit drug use and mental illnessMark S Sulkowski, David L Thomas
Gastroenterology|February 27, 2010
Interleukin-28b: a key piece of the hepatitis C virus recovery puzzleChloe L Thio, David L Thomas
Journal of Addictive Diseases|August 7, 2008
Detection of liver disease in injection drug usersDavid L Thomas, Mark S Sulkowski
JAMA|March 29, 2012
Screening for HCV infection in jailsAnne C Spaulding, David L Thomas
Annals of Internal Medicine|February 1, 2003
Hepatitis C in the HIV-Infected PersonMark S Sulkowski, David L Thomas
AIDS Research and Human Retroviruses|July 13, 2018
HIV-1 Infection and Type 1 Interferon: Navigating Through Uncertain WatersSho Sugawara, David L Thomas, Ashwin Balagopal
Magnetic Resonance in Medicine|February 27, 2013
Orthogonalizing crusher and diffusion-encoding gradients to suppress undesired echo pathways in the twice-refocused spin echo diffusion sequenceZoltán Nagy, David L Thomas, Nikolaus Weiskopf
Current Opinion in HIV and AIDS|November 6, 2018
Creating demand for long-acting formulations for the treatment and prevention of HIV, tuberculosis, and viral hepatitisCharles Flexner, David L Thomas, Susan Swindells
Pageof 49